Akebia Therapeutics
AKBA
#9606
Rank
HK$0.83 B
Marketcap
HK$3.02
Share price
-8.71%
Change (1 day)
-75.58%
Change (1 year)

EPS for Akebia Therapeutics (AKBA)

EPS in 2026 (TTM): -HK$1.25

According to Akebia Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$1.25. In 2025 the company made an earnings per share (EPS) of -HK$0.16 an increase over its 2024 EPS that were of -HK$2.59.

EPS history for Akebia Therapeutics from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$1.25698.43%
2025-HK$0.16-93.94%
2024-HK$2.59-16.83%
2023-HK$3.11-23.7%
2022-HK$4.08-69.41%
2021-HK$13.33-38.63%
2020-HK$21.7117.37%
2019-HK$18.502.79%
2018-HK$18.00

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$52.36-4,274.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$41.15-3,381.25%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
HK$136.24-10,962.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-HK$52.52 4,087.50%๐Ÿ‡บ๐Ÿ‡ธ USA